BACKGROUND
The impact of recent trends in the burden of myocarditis has not been reported in detail.
OBJECTIVES
This study aims to estimate the global, regional, and national burden of myocarditis from 1990 to 2023, using data from the GBD (Global Burden of Disease, Injuries, and Risk Factors Study) 2023.
METHODS
A...
Sooji Lee, Hayeon Lee, Min Seo Kim et al.· Journal of the American Coll...· 0 citations
BACKGROUND
Exposure to chewing tobacco is a known health risk factor but has received less attention than smoking in global tobacco control efforts. As the evidence base linking chewing tobacco use to poor health grows, it is essential to closely track the changing use of chewing tobacco distinct from other forms of sm...
G. Gil, Jason A. Anderson, Xiao-Chen Dai et al.· Lancet Global Health· 1 citation
BACKGROUND
The rapid rise in the burden of non-communicable disease (NCDs) in African communities has resulted in a considerable mortality, disability, and economic burden. A comprehensive evaluation of incidence, deaths, disability-adjusted life-years (DALYs), and attributable risk factors related to NCDs by sex, and...
A. Awedew, Mihretu Jegnie, K. Abate et al.· Lancet Global Health· 0 citations
It is estimated that SHS remains a substantial driver of global health loss, particularly through cardiovascular and paediatric respiratory diseases, and growing absolute numbers of exposed individuals in several regions underscore the urgent need for accelerated implementation and enforcement of comprehensive tobacco...
L. Flor, Jason A. Anderson, Brooks W. Morgan et al.· Lancet Public Health· 0 citations
An elevated 10-year ASCVD risk was associated with a two-fold increase in the risk of echocardiographic and ECG LVH in a population of Nigerian hypertensives, suggesting the use of the ASCVD risk score may facilitate timely referrals for the diagnosis and management of LVH.
O. Abiodun, Tina Anya· Nigerian Postgraduate Medica...· 0 citations
Intensifying pharmacological treatment in sub-Saharan Africa, including antihypertensives, lipid-lowering agents, antidiabetic medications, and aspirin, should create an opportunity for improved overall cardiovascular and metabolic prevention.
Dong-Yan Zhang, De-Wei An, Yu-Ling Yu et al.· Journal of Hypertension· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.